CD274 and triple-negative breast carcinoma: While no difference in the different metastatic sites of non-small cell lung carcinomas has been found [63], a lower PD-L1 expression has been described in skin, liver, and bone metastases of triple-negative breast cancer; however, the same expression levels have been found for lung, soft tissue, and lymph node metastases [64].